• 대한임상검사과학회지
• /
• 제56권1호
• /
• pp.32-42
• /
• 2024

본 연구는 용혈의 영향과 허용 hemolysis index (HI)를 조사하기 위해 용혈된 검체와 재채혈된 검체의 결과를 비교하였다. 용혈 전·후, alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), amylase (Amy), direct bilirubin (D-bil), total bilirubin (T-bil), creatine phosphokinase (CK), gamma glutamyl transferase (GGT), iron, potassium (K), lactate dehydrogenase (LDH), magnesium (Mg), phosphorus (Phos), total protein (TP), uric acid (UA) 항목에서 유의미한 결과를 보였다. LDH, K, iron, AST, CK, GGT, TP, Amy, Phos는 용혈 정도와 결과 사이에 높은 상관관계가 있었다. Quality control (QC) high standard deviation (SD)을 이용하여 구한 허용 HI, HI^QChigh를 비교했을 때 AST, D-bil, CK, LDH는 비슷했지만 Amy, GGT, K, iron, Phos, TP는 장비의 cut-off HI보다 낮은 HI에서부터 영향 받았으며 ALP, ALT는 높게 나왔다. 그리고 paired t-test를 통해 유의미한 결과가 없었던 albumin, cholesterol, triglyceride 항목에서도 HI>200에서는 유의미한 결과가 나왔기 때문에 재채혈하는 것이 바람직하다고 생각되며 HI<100일 때 영향을 받는 항목들이 있었던 연구 결과를 기반하여 약한 용혈이 나타나는 HI>50부터 용혈 기준을 설정하는 것을 권장한다.

• Journal of Chest Surgery
• /
• 제17권1호
• /
• pp.157-166
• /
• 1984

These biologic test procedures are designed to test the suitability of P.V.C. made in Korea intended for parenteral preparation, which were based on the U.S. Pharmacopeia XIX "Biologic Test-Plastic Container", Official from July 1, 1975. Healthy adult human blood and rabbits weighing 2\ulcorner.2Kg were used for test materials. Sample P.V.C. were sampled from the medical equipments made in Korea randomly and Control P.V.C. were sampled from the standardized Cobe and Polystan P.V.C. tubes. P.V.C. extract was prepared from a homogeneous P.V.C. samples by incubating 60 square centimeters of the sample per 20 millimeters of sterile pyrogen-free saline at 70\ulcorner for 72 hours or autoclaving at 120\ulcorner for 1 hour. The Implantation Test was designed to evaluate the reaction of living tissue to the plastic by the method of the implantation of the Sample itself into animal tissue. The Systemic Injection Test, the Intracutaneous Test, and the remainders were designed to determine the biological response of animals to plastics by the single-dose injection of specific extracts prepared from a Sample. The results are as follows; 1.Implantation Test - No significant difference for reactions was noted between the Sample treated animal and the Control after 72 hours of implantation. 2.Systemic Toxicity Injection Test - No sign of toxicity and/or death immediately after injection and at 4, 24, 48 hours respectfully after injection. 3.Intracutaneous Test - None of the animals treated with the Sample showed a significantly greater reaction than the observed in the animals treated with Blank. 4.Pyrogen Assay-Only one animal treated with the Sample showed the maximal rise of rectal temperature about 0.2\ulcorner after 3 hours of injection, but remainders showed no change. 5.Hemolytic Index - The positive Control tube of distilled water exhibited complete hemolysis while the negative Control tube and P.V.C. extract were negative demonstrating no hemolysis. 6.Cell Morphology of Erythrocytes and Leukocytes on Stored, Heparinized Human Blood -- There was no significant difference in the morphology of either the Control or Sample extract. 7.Clotting Mechanism of Human Blood in vitro - After allowing to the P.V.C. extract at room temperature for 5 Hours and at 10\ulcorner for 24 hours, there was no appreciable difference in Prothrombin Time under these conditions. 8.Clotting Mechanism of Rabbit in vivo - At the termination of 5 days after intraperitoneal injection of the P.V.C. extract, no significant changes in Clotting Time were observed. According to the above results, it could be concluded that the P.V.C. made in Korea was acceptable for parenteral preparation, especially treated with physiologic saline and/or human blood.man blood.